C
C. Michael Samson
Researcher at New York Eye and Ear Infirmary
Publications - 13
Citations - 1088
C. Michael Samson is an academic researcher from New York Eye and Ear Infirmary. The author has contributed to research in topics: Uveitis & Panuveitis. The author has an hindex of 8, co-authored 13 publications receiving 1017 citations. Previous affiliations of C. Michael Samson include Manhattan Eye, Ear and Throat Hospital & Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
Wolfgang Hueber,Dhavalkumar D. Patel,Thaddeus P. Dryja,Andrew M Wright,Irina Koroleva,Gerard Bruin,Christian Antoni,Zoe Diana Draelos,Michael H. Gold,Patrick Durez,Paul P. Tak,Juan J. Gomez-Reino,C. Stephen Foster,Rosa Y. Kim,C. Michael Samson,Naomi S. Falk,David S. Chu,David Callanan,Quan Dong Nguyen,Kristine Rose,Asifa Haider,Franco Di Padova +21 more
TL;DR: The results demonstrate that IL-17A participates in psoriasis, rheumatoid arthritis, and uveitis and that the antibody against this cytokine may be an effective therapeutic agent, and warrant larger clinical trials to assess further the safety and efficacy of AIN457.
Journal ArticleDOI
Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
Howard F Fine,Inna Zhitomirsky,K. Bailey Freund,Gaetano R. Barile,Belinda L. Shirkey,C. Michael Samson,Lawrence A. Yannuzzi +6 more
TL;DR: Bvacizumab and ranibizumAB were effective at improving visual acuity over 6 months in a small series of patients with MFC-associated CNV.
Journal ArticleDOI
Seronegative spondyloarthropathies and the eye
Amro Ali,C. Michael Samson +1 more
TL;DR: Evidence suggests both genetic and environmental factors in its pathogenesis, including tumor necrosis factor-alpha inhibitors, may be effective in the control of chronic uveitis in patients with spondyloarthropathy.
Journal ArticleDOI
Panuveitis With Exudative Retinal Detachments After Vaccination Against Human Papilloma Virus.
Kunal K. Dansingani,Mihoko Suzuki,Jonathan Naysan,C. Michael Samson,Richard F. Spaide,Yale L. Fisher +5 more
TL;DR: A 20-year-old white woman presented with bilateral acute visual loss, panuveitis, and exudative retinal detachments 3 weeks after a second dose of quadrivalent human papillomavirus (HPV4) vaccine and was treated with oral prednisolone for 6 weeks and responded rapidly.
Journal ArticleDOI
A Case of Corneal Neovascularization Misdiagnosed as Total Limbal Stem Cell Deficiency.
TL;DR: A 61-year-old woman with a history of bilateral idiopathic scleritis, keratitis, and uveitis was diagnosed with total LSCD in her left eye based on clinical presentation alone and confirmed as a candidate for limbal transplantation at several major tertiary eye care centers in the United States.